Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA in Shoulder Arthroscopy
NCT06920264Phase 1Completed
- Sponsor
- St. Louis Joint Replacement Institute
- Start
- Jul 2021
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in postoperative pain comparing TXA Group with Placebo Group (2 arms). Primary endpoint: Postoperative Opioid Consumption at 72 hours. Started Jul 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06920264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06920264.